• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Enzymatic Conversion of Group A Blood to Universal Group O Blood

June 26, 2019

As reported in Nature Microbiology, researchers have identified a set of enzymes isolated from human gut bacteria that convert the A antigen on red blood cells to the H antigen. Since the mucus lining of the intestines serves as a source of nutrition for bacteria comprising the human gut microbiome and this lining also contains A and B antigen structures, the researchers constructed a metagenomic library of ~19,500 fosmids from fecal matter provided by a group AB+ donor and performed several rounds of screenings, sequencing, and in-depth analysis of fosmids containing A-antigen-cleaving activity. The study identified a set of enzymes (a deacetylase and a galactosaminidase) from Flavonifractor plautii which efficiently converted group A antigens to H antigens, as found on O red blood cells, via a galactosamine intermediate. These enzymes work efficiently at a low concentration in whole blood and can be removed via standard blood processing protocols. Although more research is needed to ensure that all traces of the A antigen have been removed, the enzymatic conversion of group A blood to universal group O blood could be a key strategy to help alleviate blood shortages.

Reference:

Rahfeld P, Sim L, Moon H, Constantinescu I, Morgan-Lang C, Hallam SJ, Kizhakkedathu JN, and SG Withers. An enzymatic pathway in the human gut microbiome that converts A to universal O type blood. Nature Microbiology 2019

 

Filed Under

  • Blood Donation
  • News
  • Serology/Genotyping

Recommended

  • Pathogen-Reduction May Help Prevent Alloimmune Platelet Refractoriness

  • FDA Issues Emergency Use Authorization for COVID-19 Convalescent Plasma

  • MiPLATE Clinical Trial: Mirasol® Pathogen Reduction Treated Platelets

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • New Erythropoietin Gene Variants Linked to Hereditary Erythrocytosis

  • Multifaceted Threats to the Blood Supply from Climate Change

  • Distinct Roles for Differently Aged Platelets

  • Anemia Treatment Bundle Improves Hemoglobin Recovery after Critical Illness

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley